Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Total Liabilities: 2023-2024

Historic Total Liabilities for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $11.9 million.

  • Upstream Bio's Total Liabilities rose 3.91% to $12.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year increase of 3.91%. This contributed to the annual value of $11.9 million for FY2024, which is 26.39% up from last year.
  • Upstream Bio's Total Liabilities amounted to $11.9 million in FY2024, which was up 26.39% from $9.4 million recorded in FY2023.
  • In the past 5 years, Upstream Bio's Total Liabilities ranged from a high of $11.9 million in FY2024 and a low of $9.4 million during FY2023.
  • In the last 2 years, Upstream Bio's Total Liabilities had a median value of $10.6 million in 2023 and averaged $10.6 million.
  • Data for Upstream Bio's Total Liabilities shows a peak YoY grew of 26.39% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Upstream Bio's Total Liabilities stood at $9.4 million in 2023, then increased by 26.39% to $11.9 million in 2024.